Efficacy and Safety of General Anesthesia Induction with Ciprofol in Hip Fracture Surgery of Elderly
Efficacy and Safety of General Anesthesia Induction with Ciprofol in Hip Fracture Surgery of Elderly Patients: A Randomized Controlled Trial.
Drug Des Devel Ther. 2024 01-Sep;():. 10.2147/DDDT.S475176Sixty elderly patients aged ≥75 years undergoing hip fracture surgery were randomized to receive either ciprofol (0.3 mg/kg, n=30) or propofol (1.5 mg/kg, n=30) for general anesthesia induction. The primary outcomes of interest were the incidences of severe hypotension and hypotension during the observation period. Secondary outcomes included success rate of induction, additional sedation requirements, loss of consciousness time, change in hypotension, heart rate, adverse events, and frequency of vasoactive drug use. Outcomes were assessed from drug infusion initiation to five minutes post-intubation. Overall, ciprofol showed a lower incidence of severe hypotension (p=0.035) and hypotension (p=0.037) compared to propofol, with more stable blood pressure (ΔMAP 31.4 ± 11.4 vs. 39.6 ± 15.7, p=0.025). The findings suggest ciprofol provides safer hemodynamic profiles than propofol during anesthesia induction in this population.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics